Search Results for 'tdf 2015'

tdf 2015 published presentations and documents on DocSlides.

TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
ID Week Review 2015
ID Week Review 2015
by briana-ranney
Brian R. Wood, MD. Assistant Professor of Medicin...
WHO ARV Forecasting Meeting
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Gilead Sciences, Inc., Foster City, CA, USA
Gilead Sciences, Inc., Foster City, CA, USA
by phoebe-click
Gilead Sciences, Inc., Foster City, CA, USA FTC/T...
Overview of HIV Epidemiology and Prevention Sciences for ke
Overview of HIV Epidemiology and Prevention Sciences for ke
by alida-meadow
Stefan Baral, MD MPH FRCPC. Center for Public Hea...
Comparison of NRTI combinations
Comparison of NRTI combinations
by tawny-fly
ZDV/3TC . vs. TDF + FTC. Study 934. ABC/3TC . vs...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Joel E. Gallant, MD, MPH
Joel E. Gallant, MD, MPH
by mastervisa
Medical Director, Specialty . Services. Southwest ...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by sportyinds
, . prodrug. of . temsavir. . (. attachment inhi...
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
by ricardo
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
Cases from the Clinic(ians):  Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
CROI 2015: Treatment and Cure Highlights
CROI 2015: Treatment and Cure Highlights
by unita
Shireesha Dhanireddy. Robert Harrington. March 17,...
CROI 2015: What’s New in Hepatitis?
CROI 2015: What’s New in Hepatitis?
by myesha-ticknor
Nina Kim, MD . Associate Professor of Medicine. D...
Novel Antiretroviral Studies and Strategies
Novel Antiretroviral Studies and Strategies
by danya
Bob Harrington, MD. University of Washington . Pre...
Susan P. Buchbinder, MD Director, Bridge HIV
Susan P. Buchbinder, MD Director, Bridge HIV
by harmony
San . Francisco Department . of Public Health. Cli...
Joseph J. Eron Jr, MD
Joseph J. Eron Jr, MD
by lois-ondreau
Joseph J. Eron Jr, MD Professor of Medicine Unive...
Second-Generation  HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan
Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan
by sherrill-nordquist
± . Ritonavir. Carey Hwang. ,. 1. Dirk Schürma...
Update on risk factors, detection, and management of neuroc
Update on risk factors, detection, and management of neuroc
by natalia-silvester
Scott Letendre, M.D.. Professor of . Medicine and...
CROI 2015: HIV Prevention Updates
CROI 2015: HIV Prevention Updates
by pamella-moone
Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...